Treatment outcomes following administration of vedolizumab in patients with moderate to severe Ulcerative colitis

(1) National and Kapodistrian University of Athens,Athens,Greece

(2) Evaggelismos-Ophthalmiatreion Athinon-Polykliniki GH,Athens,Greece

(3) General Hospital of Nikea and Pireaus Ag Panteleimon,Nikea,Greece

(4) Alexandra Hospital,Athens,Greece

(5) Tzaneio Hospital Piraeus,Pireaus,Greece



This item was part of the IBD II (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019